menu

Medical Program: Advancing Novel Therapeutics to Address Unmet Mental Health Needs

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Advancing Novel Therapeutics to Address Unmet Mental Health Needs

Advancing Novel Therapeutics to Address Unmet Mental Health Needs
RestartResume
Tune in to hear a biopharmaceutical industry leader discuss a developing treatment that can potentially address 600,000 suicidality cases each year.
  • Overview

    Seelos Therapeutics is leading the charge against central nervous system (CNS) disorders by advancing late-stage therapeutic candidates with proven mechanisms of action for patients with suicidality in post-traumatic stress disorder (PTSD) and major depressive disorder (MDD). And Mario Nacinovich welcomes Dr. Raj Mehra, Chairman, Founder, and CEO of Seelos Therapeutics, to hear all about it.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.